DUCTAL ADENOCARCINOMA OF PANCREAS
Clinical trials for DUCTAL ADENOCARCINOMA OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new DUCTAL ADENOCARCINOMA OF PANCREAS trials appear
Sign up with your email to follow new studies for DUCTAL ADENOCARCINOMA OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New antibody TST001 targets Hard-to-Treat cancers in early trial
Disease control Recruiting nowThis study tests a new drug called TST001, an antibody that targets a protein called Claudin18.2 found on some cancer cells. It is given alone or with chemotherapy to people with advanced solid tumors that cannot be removed by surgery or have spread. The main goals are to check s…
Matched conditions: DUCTAL ADENOCARCINOMA OF PANCREAS
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New app aims to ease pancreatic cancer care at home
Symptom relief Recruiting nowThis study is testing an app called PancreasPlus for people with pancreatic cancer. The app helps patients track symptoms, get information, and communicate with their care team from home. Researchers want to see if using the app improves quality of life, reduces anxiety, and cuts…
Matched conditions: DUCTAL ADENOCARCINOMA OF PANCREAS
Phase: NA • Sponsor: Casa di Cura Dott. Pederzoli • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC